12 August 2022>: Original Paper
Retrospective Study from a Single Center in Romania of 347 Renal Transplant Patients Treated with Tacrolimus, Mycophenolate, and Steroids to Evaluate the Association Between Anti-HLA Antibodies and 5-Year Graft Survival
Ion Mărunţelu 12ABCDEF , Claudiu Eduard Nistor 2CEF* , Bogdan Mihai Cristea 2CE , Corina Andreea Rotarescu 12BCD , Andreea Mirela Caragea 2B , Maria Tizu 2B , Ileana Constantinescu 12ADDOI: 10.12659/AOT.937267
Ann Transplant 2022; 27:e937267
Table 2 Prevalence of posttransplant de novo HLA antibodies.
HLA antibodies | Patients n (%) |
---|---|
Total | 320 (100%) |
Not detected | 272 (85%) |
Detected | 48 (15%) |
Class I | |
Not detected | 298 (93.13%) |
Detected | 22 (6.87%) |
Class II | |
Not detected | 283 (86.93%) |
Detected | 37 (13.07%) |
HLA – human leukocyte antigen. |